A review of health utilities using the EQ-5D in studies of cardiovascular disease
Top Cited Papers
Open Access
- 27 January 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Health and Quality of Life Outcomes
- Vol. 8 (1), 13
- https://doi.org/10.1186/1477-7525-8-13
Abstract
Background: The EQ-5D has been extensively used to assess patient utility in trials of new treatments within the cardiovascular field. The aims of this study were to review evidence of the validity and reliability of the EQ-5D, and to summarise utility scores based on the use of the EQ-5D in clinical trials and in studies of patients with cardiovascular disease. Methods: A structured literature search was conducted using keywords related to cardiovascular disease and EQ-5D. Original research studies of patients with cardiovascular disease that reported EQ-5D results and its measurement properties were included. Results: Of 147 identified papers, 66 met the selection criteria, with 10 studies reporting evidence on validity or reliability and 60 reporting EQ-5D responses (VAS or self-classification). Mean EQ-5D index-based scores ranged from 0.24 (SD 0.39) to 0.90 (SD 0.16), while VAS scores ranged from 37 (SD 21) to 89 (no SD reported). Stratification of EQ-5D index scores by disease severity revealed that scores decreased from a mean of 0.78 (SD 0.18) to 0.51 (SD 0.21) for mild to severe disease in heart failure patients and from 0.80 (SD 0.05) to 0.45 (SD 0.22) for mild to severe disease in angina patients. Conclusions: The published evidence generally supports the validity and reliability of the EQ-5D as an outcome measure within the cardiovascular area. This review provides utility estimates across a range of cardiovascular subgroups and treatments that may be useful for future modelling of utilities and QALYs in economic evaluations within the cardiovascular area.Keywords
This publication has 91 references indexed in Scilit:
- Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trialBMJ, 2007
- Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational studyBMJ, 2007
- Health Utilities Using the EQ-5D in Studies of CancerPharmacoEconomics, 2007
- Influence of socioeconomic status on clinical outcomes and quality of life after percutaneous coronary interventionJournal of Epidemiology and Community Health, 2006
- The Dutch tariff: results and arguments for an effective design for national EQ‐5D valuation studiesHealth Economics, 2006
- Psychosocial impact of finding small aneurysms that are left untreated in patients previously operated on for ruptured aneurysmsJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Health-related quality of life after interventional or conservative strategy in patients with unstable angina or non–ST-segment elevation myocardial infarction: One-year results of the third randomized intervention trial of unstable angina (RITA-3)Journal of the American College of Cardiology, 2005
- Measuring inconsistency in meta-analysesBMJ, 2003
- Quantifying heterogeneity in a meta-analysisStatistics in Medicine, 2002
- EQ-SD: a measure of health status from the EuroQol GroupAnnals of Medicine, 2001